Whitehawk Therapeutics (WHWK) Other Non-Current Assets (2016 - 2026)

Whitehawk Therapeutics (WHWK) has 11 years of Other Non-Current Assets data on file, last reported at $1.7 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 23.33% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 23.33% YoY) and the FY2025 annual result came in at $1.8 million, up 29.66% from the prior year.
• Other Non-Current Assets retreated to $1.7 million in Q1 2026 per WHWK's latest filing, from $1.8 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.3 million in Q1 2022 and bottomed at $1.4 million in Q1 2025.
• The 5-year median for Other Non-Current Assets is $1.9 million (2023), against an average of $1.9 million.
• The widest annual swing landed in 2022, when Other Non-Current Assets surged 11585.0%; it then declined 25.03% in 2024.
• Tracing WHWK's Other Non-Current Assets over 5 years: stood at $2.2 million in 2022, then decreased by 14.33% to $1.9 million in 2023, then decreased by 25.03% to $1.4 million in 2024, then climbed by 29.66% to $1.8 million in 2025, then dropped by 7.33% to $1.7 million in 2026.
• Per Business Quant, the three latest WHWK Other Non-Current Assets figures stand at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $2.0 million (Q3 2025).

Peer Comparison